PLUR
Pluri Inc.
NASDAQ · Healthcare · Biotechnology · IL
$1.36
−0.73%Margins
Gross margin
19.0%
EBITDA margin
-2410.8%
EBIT margin
-2412.1%
Net margin
-2424.7%
FCF margin
-2010.1%
140.6%
Return on equity
-100.4%
Return on assets
-173.2%
Return on invested capital
0.04x
Asset turnover
-$20.4M
Cash from operations
$0.80
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026